Código QR

FRAILTY ASSESSMENT AS PREDICTOR OF BLEEDING FOR PATIENTS TREATED WITH ACALABRUTINIB

Introduction: The American Society of Clinical Oncology (ASCO) promotes the routine use of a comprehensive geriatric assessment, particularly emphasizing frailty, to identify vulnerabilities not detected in the standard clinical evaluation. However, frailty remains an under-explored topic in Chronic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: TX Carneiro, JLS Sales, JS Tavares, IJM Wanderley, JKD Santos, LBC Leão, LDS Pimentel, NS Moraes
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2023-10-01
Colección:Hematology, Transfusion and Cell Therapy
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2531137923005631
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!